iOnctura starts randomised phase 1/2 trial in lung cancer treatment

8th May 2025 Uncategorised 0

Study explores whether PI3Kδ targeting could combat resistance

More: iOnctura starts randomised phase 1/2 trial in lung cancer treatment
Source: News